These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 2019939

  • 1. Suppression of gastric acid secretion by intravenous administration of famotidine in children.
    Treem WR, Davis PM, Hyams JS.
    J Pediatr; 1991 May; 118(5):812-6. PubMed ID: 2019939
    [Abstract] [Full Text] [Related]

  • 2. Gastric acid suppression is greater during intravenous ranitidine infusion versus bolus injections of famotidine.
    Hogan DL, McQuaid KR, Koss MA, Crombie DL, Hunter S, Metz C, Euler AR, Isenberg JI.
    Aliment Pharmacol Ther; 1993 Oct; 7(5):537-41. PubMed ID: 8280822
    [Abstract] [Full Text] [Related]

  • 3. Statistical interpretation of the antisecretory effect of famotidine measured by intragastric pH-metry.
    Hunyady B, Juricskay I, Nagy L, Garamszegi M, Vincze A, Mózsik G.
    Eur J Clin Pharmacol; 1996 Oct; 50(6):449-56. PubMed ID: 8858270
    [Abstract] [Full Text] [Related]

  • 4. Plasma famotidine concentration versus intragastric pH in patients with upper gastrointestinal bleeding and in healthy subjects.
    Echizen H, Shoda R, Umeda N, Ishizaki T.
    Clin Pharmacol Ther; 1988 Dec; 44(6):690-8. PubMed ID: 2904311
    [Abstract] [Full Text] [Related]

  • 5. Bolus infusion of famotidine: effects on gastric pH by repeated 12-hour doses of 20 mg in postoperative patients.
    Savarino V, Mela GS, Zentilin P, Larghero G, Cutela P, Mele MR, Vassallo A, Mansi C, Dallorto E, Celle G.
    J Clin Pharmacol; 1994 Feb; 34(2):148-52. PubMed ID: 8163715
    [Abstract] [Full Text] [Related]

  • 6. Pharmacokinetics and pharmacodynamics of famotidine and ranitidine in critically ill children.
    Madani S, Kauffman R, Simpson P, Lehr VT, Lai ML, Sarniak A, Tolia V.
    J Clin Pharmacol; 2014 Feb; 54(2):201-5. PubMed ID: 24258773
    [Abstract] [Full Text] [Related]

  • 7. Comparison of effects of oral and intravenous famotidine on inhibition of nocturnal gastric acid secretion.
    Ryan JR, Vargas R, McMahon FG, Chremos AN.
    Am J Med; 1986 Oct 24; 81(4B):60-4. PubMed ID: 2877576
    [Abstract] [Full Text] [Related]

  • 8. Comparison of an intravenous bolus of famotidine and Mylanta II for the control of gastric pH in critically ill patients.
    Wilson P, Clark GW, Anselmino M, Welch NT, Singh S, Perdikis G, Hinder RA.
    Am J Surg; 1993 Dec 24; 166(6):621-4; discussion 624-5. PubMed ID: 8273840
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Maintenance of gastric pH above 6 with intravenous famotidine in patients with a bleeding duodenal ulcer.
    Delchier JC, el Amine I, Roudot-Thoraval F, Elouaer-Blanc L, Lamarque D, Stanescu L.
    Aliment Pharmacol Ther; 1995 Apr 24; 9(2):191-6. PubMed ID: 7605861
    [Abstract] [Full Text] [Related]

  • 12. The frequency of oral famotidine administration influences its effect on gastric pH in cats over time.
    Golly E, Odunayo A, Daves M, Vose J, Price J, Hecht S, Steiner JM, Hillsman S, Tolbert MK.
    J Vet Intern Med; 2019 Mar 24; 33(2):544-550. PubMed ID: 30746763
    [Abstract] [Full Text] [Related]

  • 13. Pharmacokinetics and pharmacodynamics of famotidine in children with gastroduodenal ulcers.
    Nagita A, Manago M, Aoki S, Mino M, Suzuki K, Ashida K.
    Ther Drug Monit; 1994 Oct 24; 16(5):444-9. PubMed ID: 7846741
    [Abstract] [Full Text] [Related]

  • 14. Effect of Helicobacter pylori status on intragastric pH during administration of lafutidine or famotidine.
    Koike T, Ohara S, Sehine H, Kawamura M, Abe Y, Inomata Y, Iijima K, Imatani A, Shimosegawa T.
    Hepatogastroenterology; 2007 Jun 24; 54(76):1280-4. PubMed ID: 17629089
    [Abstract] [Full Text] [Related]

  • 15. The comparative effects of single intravenous doses of omeprazole and famotidine on intragastric pH.
    Abe Y, Inamori M, Togawa J, Kikuchi T, Muramatsu K, Chiguchi G, Kawamura H, Kobayashi N, Kirikoshi H, Sakaguchi T, Takamura T, Nakajima A, Ueno N, Sekihara H.
    J Gastroenterol; 2004 Jan 24; 39(1):21-5. PubMed ID: 14767730
    [Abstract] [Full Text] [Related]

  • 16. Maintenance of intragastric pH > 4 with famotidine in duodenal ulcer patients: factors influencing drug requirements.
    Delchier JC, Roudot-Thoraval F, Stanescu L, Deharvengt MC, Elouaer Blanc L.
    Gut; 1994 Jun 24; 35(6):750-4. PubMed ID: 8020798
    [Abstract] [Full Text] [Related]

  • 17. Single bedtime dose of famotidine: assessment of its antisecretory action by 24-hour intragastric pH monitoring.
    Savarino V, Picciotto A, Magnolia MR, Scalabrini P, Mela GS, Celle G.
    J Clin Pharmacol; 1987 Oct 24; 27(10):790-3. PubMed ID: 2892864
    [Abstract] [Full Text] [Related]

  • 18. A randomized clinical trial comparing the efficacy of ranitidine and famotidine on intragastric acidity in critically ill pediatric patients.
    Aanpreung P, Vanprapar N, Susiva C, Parkpreaw C, Boonyachart C.
    J Med Assoc Thai; 1998 Mar 24; 81(3):185-9. PubMed ID: 9623009
    [Abstract] [Full Text] [Related]

  • 19. Continuous intravenous infusions of famotidine maintain high intragastric pH in duodenal ulcer.
    Merki HS, Witzel L, Kaufman D, Kempf M, Neumann J, Röhmel J, Walt RP.
    Gut; 1988 Apr 24; 29(4):453-7. PubMed ID: 3286384
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.